SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

GDR (GDR) News

Follow GDR (GDR) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 3 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol GDR Asset equity Sector Markets 90 days 3 Updated Sep 03, 2026, 12:42 PM UTC Open live news feed Open GDR chart & news
L GDR: Rapid pharmacogenetic testing adoption accelerates, with key NHS and international milestones ahead Rapid pharmacogenetic testing solutions are driving revenue growth and adoption in the UK and internationally, with two CE-IVD certified products addressing critical clinical needs. Key milestones include NICE guidance a EARNINGS | Sep 03, 2026, 12:42 PM UTC L GDR: Rapid pharmacogenetic testing adoption accelerates, with national and international scale in sight Rapid pharmacogenetic testing solutions are driving revenue growth and adoption in UK and international markets, with two CE-IVD certified products addressing critical needs in neonatal and stroke care. National adoption EARNINGS | Sep 03, 2026, 11:21 AM UTC L Genedrive PLC director/PDMR notification received Genedrive PLC has filed a director/PDMR notification. EQUITY | Sep 01, 2026, 06:01 AM UTC